Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy

被引：8
|
作者：
McGann, Mary [1 ]
Davis, James A. [1 ]
Gaffney, Kelly J. [1 ]
Smith, Deidra [1 ]
Edwards, Kathy [1 ]
Hess, Brian T. [1 ]
Hashmi, Hamza [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC USA
来源：
TRANSPLANTATION AND CELLULAR THERAPY | 2022年 / 28卷 / 09期
关键词：
LISOCABTAGENE MARALEUCEL;
D O I：
10.1016/j.jtct.2022.06.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：583 / 585
页数：3
相关论文
共 50 条
  • [21] Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher J.
    Atrash, Shebli
    Khouri, Jack
    Voorhees, Peter M.
    Dima, Danai
    Simmons, Gary
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Arai, Sally
    Miklos, David B.
    Wagner, Charlotte B.
    Davis, James
    Sborov, Douglas W.
    Nishihori, Taiga
    Alsina, Melissa
    Locke, Frederick L.
    Gonzalez, Rebecca
    Kocoglu, M. Hakan
    Sannareddy, Aishwarya
    Afrough, Aimaz
    McGuirk, Joseph P.
    Shune, Leyla O.
    Patel, Krina
    Hansen, Doris K.
    [J]. BLOOD, 2022, 140 : 10377 - 10379
  • [22] CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY FOR MULTIPLE MYELOMA IN THE US: REAL-WORLD EVALUATION OF PATIENT CHARACTERISTICS AND TREATMENT PATTERNS
    Kish, J.
    Pfeffer, D.
    Cyhaniuk, A.
    Lussier, C.
    Nayak, P.
    Liu, R.
    Prasad, S.
    Sehgal, P.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S58 - S58
  • [23] Chimeric Antigen Receptor T Cell Therapy for γδ T Cell Malignancies
    Wawrzyniecka, Patrycja A.
    Pule, Martin A.
    Maciocia, Paul M.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 267 - 268
  • [24] Chimeric antigen receptor T-cell therapy
    Burge, Cale
    Vanguru, Vinay
    Ho, Phoebe Joy
    [J]. AUSTRALIAN PRESCRIBER, 2023, 46 (02) : 36 - 39
  • [25] Chimeric Antigen Receptor T-Cell Therapy
    Ogba, Ndiya
    Arwood, Nicole M.
    Bartlett, Nancy L.
    Bloom, Mara
    Brown, Patrick
    Brown, Christine
    Budde, Elizabeth Lihua
    Carlson, Robert
    Farnia, Stephanie
    Fry, Terry J.
    Garber, Morgan
    Gardner, Rebecca A.
    Gurschick, Lauren
    Kropf, Patricia
    Reitan, Jeff J.
    Sauter, Craig
    Shah, Bijal
    Shpall, Elizabeth J.
    Rosen, Steven T.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1093 - 1106
  • [26] Chimeric Antigen Receptor T Cell Therapy in Hematology
    Ataca, Pinar
    Arslan, Onder
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (04) : 285 - 294
  • [27] The Future of Chimeric Antigen Receptor T Cell Therapy
    Smith, Eric L.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1215 - 1219
  • [28] Chimeric Antigen Receptor T-Cell Therapy
    Rasheed, Azgar Abdul
    Koyyala, Venkata Pradeep Babu
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 89 - 92
  • [29] Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis
    Puckrin, Robert
    Stewart, Douglas A.
    Shafey, Mona
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 218.e1 - 218.e4
  • [30] Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center
    Borogovac, Azra
    Keruakous, Amany
    Bycko, Michelle
    Holter Chakrabarty, Jennifer
    Ibrahimi, Sami
    Khawandanah, Mohamad
    Selby, George B.
    Yuen, Carrie
    Schmidt, Sarah
    Autry, Marcus T.
    Al-Juhaishi, Taha
    Wieduwilt, Matthew J.
    Asch, Adam S.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1025 - 1027
12345